Overview
A topical glucocorticoid used in the treatment of eczema.
Indication
A topical anti-inflammatory product for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Associated Conditions
- Dermatosis
- Inflammation
- Pruritus
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2024/07/16 | Phase 1 | Recruiting | |||
2023/11/18 | Not Applicable | Recruiting | |||
2014/11/26 | Not Applicable | Withdrawn | |||
2014/06/26 | N/A | Completed | |||
2013/03/01 | Early Phase 1 | Completed | |||
2011/11/10 | Phase 2 | Completed | |||
2011/08/24 | Phase 2 | Completed | |||
2010/01/14 | Phase 4 | Completed | |||
2009/01/09 | Phase 4 | Completed | |||
2008/04/28 | Phase 2 | Terminated |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Teligent Pharma, Inc. | 52565-040 | TOPICAL | 0.5 mg in 1 g | 8/12/2016 | |
IPG PHARMACEUTICALS, INC. | 71085-005 | TOPICAL | 0.5 mg in 1 g | 2/15/2017 | |
A-S Medication Solutions | 50090-2419 | TOPICAL | 0.5 mg in 1 g | 12/6/2022 | |
Aidarex Pharmaceuticals LLC | 33261-560 | TOPICAL | 0.5 mg in 1 g | 8/23/2018 | |
Asclemed USA, Inc. | 76420-509 | TOPICAL | 1 mg in 1 g | 12/16/2023 | |
NuCare Pharmaceuticals,Inc. | 68071-1754 | TOPICAL | 0.5 mg in 1 g | 2/11/2021 | |
NuCare Pharmaceuticals, Inc. | 66267-973 | TOPICAL | 0.5 mg in 1 g | 1/11/2021 | |
NuCare Pharmaceuticals,Inc. | 68071-4921 | TOPICAL | 0.5 mg in 1 g | 2/18/2021 | |
Preferred Pharmaceuticals Inc. | 68788-8105 | TOPICAL | 0.5 mg in 1 g | 6/8/2023 | |
NuCare Pharmaceuticals,Inc. | 68071-2808 | TOPICAL | 0.5 mg in 1 g | 8/8/2022 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Fluocinonide Acetate and Borneol Cream | 国药准字H42022579 | 化学药品 | 乳膏剂 | 5/19/2020 | |
Fluocinonide Acetate and Borneol Cream | 国药准字H41024450 | 化学药品 | 乳膏剂 | 3/5/2020 | |
Fluocinonide Acetate and Borneol Cream | 国药准字H42022429 | 化学药品 | 乳膏剂 | 6/29/2020 | |
Fluocinonide Acetate and Borneol Cream | 国药准字H34022183 | 化学药品 | 乳膏剂 | 9/21/2020 | |
Fluocinonide Acetate and Borneol Cream | 国药准字H31022863 | 化学药品 | 乳膏剂 | 1/15/2020 | |
Fluocinonide Acetate and Borneol Cream | 国药准字H34022116 | 化学药品 | 乳膏剂 | 5/14/2020 | |
Fluocinonide Acetate and Borneol Cream | 国药准字H20204037 | 化学药品 | 乳膏剂 | 8/21/2020 | |
Fluocinonide Acetate and Borneol Cream | 国药准字H12021008 | 化学药品 | 乳膏剂 | 12/4/2019 | |
Fluocinonide Acetate and Borneol Cream | 国药准字H41024618 | 化学药品 | 乳膏剂 | 3/27/2020 | |
Fluocinonide Acetate and Borneol Cream | 国药准字H34023195 | 化学药品 | 乳膏剂 | 11/6/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.